6-aminoisoquinoline compounds

Details 6-aminoisoquinoline compounds 6-aminoisoquinoline compounds

2010-02-08

2011-10-11

Chandrakumar, Nizal (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S148000, C546S152000

Reexamination Certificate

active

08034943

ABSTRACT:
6-Aminoisoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.

REFERENCES:
patent: 5798380 (1998-08-01), Kaufman et al.
patent: 5891646 (1999-04-01), Barak et al.
patent: 6110693 (2000-08-01), Barak et al.
patent: 6110912 (2000-08-01), Kaufman et al.
patent: 6362177 (2002-03-01), Shiota et al.
patent: 6586425 (2003-07-01), Kaufman et al.
patent: 6787534 (2004-09-01), Haneda et al.
patent: 7268143 (2007-09-01), Jagtap et al.
patent: 7329684 (2008-02-01), Mjalli et al.
patent: 7345158 (2008-03-01), Egashira et al.
patent: 7361678 (2008-04-01), Mjalli et al.
patent: 7374891 (2008-05-01), Shahbaz
patent: 7378498 (2008-05-01), Worley et al.
patent: 7470787 (2008-12-01), deLong et al.
patent: 7671205 (2010-03-01), deLong et al.
patent: 2004/0091946 (2004-05-01), Oakley et al.
patent: 2005/0032125 (2005-02-01), Oakley et al.
patent: 2005/0176712 (2005-08-01), Wakabayashi et al.
patent: 2005/0282805 (2005-12-01), Hangeland et al.
patent: 2006/0270670 (2006-11-01), Chew et al.
patent: 2007/0111983 (2007-05-01), Fong
patent: 2007/0123561 (2007-05-01), Lee et al.
patent: 2007/0129404 (2007-06-01), Hagihara et al.
patent: 2007/0135499 (2007-06-01), deLong et al.
patent: 2007/0149473 (2007-06-01), Chatterton et al.
patent: 2007/0149548 (2007-06-01), Hellberg et al.
patent: 2007/0167444 (2007-07-01), Kuramochi et al.
patent: 2007/0238741 (2007-10-01), Nagarathnam et al.
patent: 2008/0021026 (2008-01-01), Kahraman et al.
patent: 2008/0021217 (2008-01-01), Borchardt
patent: 2008/0058384 (2008-03-01), Lee et al.
patent: 2008/0096238 (2008-04-01), Sharif et al.
patent: 2008/0125427 (2008-05-01), Sehon et al.
patent: 2008/0139595 (2008-06-01), Schirok et al.
patent: 2008/0153799 (2008-06-01), Laurent et al.
patent: 2008/0153813 (2008-06-01), Chen et al.
patent: 2008/0161297 (2008-07-01), Bosanac et al.
patent: 2008/0167340 (2008-07-01), deLong et al.
patent: 2008/0194584 (2008-08-01), Birault et al.
patent: 2008/0275029 (2008-11-01), Berdini et al.
patent: 2009/0005321 (2009-01-01), Zimmer et al.
patent: 2009/0069371 (2009-03-01), deLong et al.
patent: 2009/0186917 (2009-07-01), deLong et al.
patent: 2010/0022585 (2010-01-01), deLong et al.
patent: 2010/0093790 (2010-04-01), deLong et al.
patent: 2010/0105650 (2010-04-01), Plettenburg et al.
patent: 2010/0144713 (2010-06-01), deLong et al.
patent: 0232569 (1987-08-01), None
patent: 0389995 (1990-10-01), None
patent: 0482939 (1992-04-01), None
patent: 1550660 (2005-07-01), None
patent: 2007236388 (2007-09-01), None
patent: 2007246466 (2007-09-01), None
patent: WO 01/53268 (2001-07-01), None
patent: WO 01/53274 (2001-07-01), None
patent: WO 01/56607 (2001-08-01), None
patent: WO 02/22576 (2002-03-01), None
patent: WO 02/32864 (2002-04-01), None
patent: WO 03/073999 (2003-09-01), None
patent: WO 03/080578 (2003-10-01), None
patent: WO 2005/020921 (2005-03-01), None
patent: WO 2005/035503 (2005-04-01), None
patent: WO 2005/037257 (2005-04-01), None
patent: WO 2006/041119 (2006-04-01), None
patent: 2006/051290 (2006-05-01), None
patent: WO 2007/008926 (2007-01-01), None
patent: WO 2007/008942 (2007-01-01), None
patent: WO 2007/060028 (2007-05-01), None
patent: 2007/065916 (2007-06-01), None
patent: WO 2007/076360 (2007-07-01), None
patent: WO 2007/076367 (2007-07-01), None
patent: WO 2007/100880 (2007-09-01), None
patent: WO 2007/142323 (2007-12-01), None
patent: WO 2008/011557 (2008-01-01), None
patent: WO 2008/011560 (2008-01-01), None
patent: WO 2008/016016 (2008-02-01), None
patent: WO 2008/036459 (2008-03-01), None
patent: WO 2008/036540 (2008-03-01), None
patent: WO 2008/049000 (2008-04-01), None
patent: WO 2008/049919 (2008-05-01), None
patent: WO 2008/054599 (2008-05-01), None
patent: WO 2008/077057 (2008-06-01), None
patent: 2008/086269 (2008-07-01), None
patent: WO 2008/077550 (2008-07-01), None
patent: WO 2008/077551 (2008-07-01), None
patent: WO 2008/077552 (2008-07-01), None
patent: WO 2008/077553 (2008-07-01), None
patent: WO 2008/077554 (2008-07-01), None
patent: WO 2008/077555 (2008-07-01), None
patent: WO 2008/077556 (2008-07-01), None
patent: WO 2008/079880 (2008-07-01), None
patent: WO 2008/079945 (2008-07-01), None
patent: WO 2009/091898 (2009-07-01), None
patent: WO 2010/011853 (2010-01-01), None
patent: 2010/126626 (2010-11-01), None
patent: 2010/127329 (2010-11-01), None
patent: 2010/127330 (2010-11-01), None
International Search Report and Written Opinion for Application No. PCT/US2010/022246 dated Nov. 10, 2010 (7 pages).
Banker, G.S. et al., Modem Pharmaceutics, Marcel Dekker, Inc., New York, (1979) Chapters 9 and 10.
C.T.F.A. Cosmetic Ingredient Handbook, “Surfactants—Emulsifying Agents”, Second Edition, The Cosmetic, Toiletry, and Fragrance Association, New York, Wenninger, J.A. et al., eds. (1992) 587-592.
Capdeville, R. et al., “Glivec (STI571, IMATINIB), A Rationally Developed, Targeted Anticancer Drug”, Nature Reviews Drug Discovery (2002) 1:493-502.
Chen, P. et al., “Identification of novel and potent isoquinoline aminooxazole-based IMPDH inhibitors,” Bioorg. Med. Chem. Lett. (2003) 13(7):1345-1348.
Dancey, J. et al., “Issues and Progress with Protein Kinase Inhibitors for Cancer Treatment”, Nature Reviews Drug Discovery (2003) 2:296-313.
Dorwald, F.Z., Side Reactions in Organic Synthesis. A Guide to Successful Synthesis Design, Wiley-VCH, Weinheim (2005) IX of Preface and 1-15.
Hackam, A.S. et al., “The Wnt Signaling Pathway in Retinal Degenerations”, IUBMB Life (2005) 57(6):381-388.
Helal, C.J. et al., “Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's disease,” Bioorg. Med. Chem. (2004) 14(22):5521-5525.
Inouye, Y. et al., “The Absolute Configurations of TRANS-1,2-Cyclopropanedicarboxylic Acid and TRANS-2-Phenylcyclopropanecarboxylic Acid”, Int'l. J. Org. Chem. (1964) 20(5):1695-1699.
Liljebris, C. et al., “Derivatives of 17-Phenyl-18,19,20-trinorprostaglandin F2α Isopropyl Ester: Potential Antiglaucoma Agents,” J. Med. Chem. (1995) 38(2):289-304.
McCutcheon's, “Emulsifiers & Detergents”, North American Edition (1994) vol. 1:236-239.
Oakley, R.H. et al. “The Cellular Distribution of Fluorescently Labeled Arrestins Provides a Robust, Sensitive and Universal Assay for Screening G Protein-Coupled Receptors,” Assay and Drug Development Technologies (2002) 1(1-1):21-30.
Penmetsa, K.V. et al., “Development of Reversed-Phase Chiral HPLC Methods Using Mass Spectrometry Compatible Mobile Phases”, J. Liquid Chroma. Rel. Tech. (2000) 23(6-10):831-839.
Penn, R.B. et al., “Pharmacological Inhibition of Protein Kinases in Intact Cells: Antagonism of Beta Adrenergic Receptor Ligand Binding by H-89 Reveals Limitations of Usefulness.” J. Pharm. Exp. Ther. (1999) 288(2):428-437.
Shankar, G. et al., “Protein-kinase-specific inhibitors block Langerhans' cell migration by inhibiting interleukin-1α release”, Immunology (1999) 96:230-235.
Stirewalt, D.L. et al., “The Role of FLT3 In Haematopoietic Malignancies”, Nature Reviews Cancer (2003) 3:650-665.
Webster, F.X. et al., “Following the Course of Resolution of Carboxylic Acids by 13C NMR Spectrometry of Amine Salts” J. Org. Chem. (1982) 47(26):5225-5226.
Westaway, S.M. et al., “N-tetrahydroquinolinyl, N-quinolinyl and N-isoquinolinyl biaryl carboxamides as antagonists of TRPV1,” Biorg. Med. Chem. Lett. (2006) 16:4533-4536.
Westra, J. et al., “p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis”, Mini-Reviews in Medicinal Chemistry (2006) 6(8):867-874.
United States Office Action for U.S. App

Affiliated with

Also associated with

Rating

6-aminoisoquinoline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-aminoisoquinoline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-aminoisoquinoline compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4292195